MENU

3 growth shares I’d buy for my kids in 2017

For the record, I don’t have kids but if did I’d buy them Class Ltd (ASX: CL1) shares, Pro Medicus Limited (ASX: PME) shares and Nanosonics Ltd (ASX: NAN) shares.

In my opinion, these three small(ish) companies offer the potential of long-term share price growth and dividend income (over time). Importantly, these three companies have characteristics that I believe make their businesses enduring.

Class Ltd

Class is a $346 million technology company. I have written about it so much that I sound — and feel — like a broken record. Nonetheless, Class provides software that is used by financial advisors and accountants to administer self-managed superannuation funds (SMSFs), a very popular investment vehicle for finance-savvy investors.

Given its size and niche market, Class should be considered a higher-risk investment. However, the company compensates for the higher risk with higher growth potential and the chance of dividend income, in my opinion. In the year ahead, analysts expect Class to pay a dividend equivalent to a yield of 1%. I expect that to grow over time.

Pro Medicus

Pro Medicus is a Melbourne-based healthcare software business. Its ‘Visage 7’ is a software application that enables radiologists and doctors to inspect regulatory-approved medical images like X-rays from almost any device. For example, a radiologist could inspect a 2GB 3D image within seconds on their iPhone. If you’re unsure just how big a 2GB image is, it’s probably the same download as if you listened to Miley Cyrus’s Wrecking Ball 600 times on repeat.

Fair to say it’s a great development for the medical imagery marketplace, which traditionally used heavy servers and bulky networks. Pro Medicus has a great product and is run by its founders. It has a dividend yield of 0.6%.

Nanosonics

Nanosonics is another healthcare business taking a simple concept and installing it in a healthcare environment. Nanosonics’ ‘Trophon’ system is increasingly used by doctors to clean and disinfect ultrasound probes.

The $900 million company has grown rapidly because its has a superior product, a simple business model and is well-run. The regulatory-approved Trophon EPR cleans ultrasound probes in just seven minutes. Nanosonics does not (yet) offer a dividend to shareholders.

Foolish Takeaway

If I had kids I would buy them shares in these companies. From a learning perspective, buying shares of companies like Woolworths Limited (ASX: WOW), Telstra Corporation Ltd (ASX: TLS) or National Australia Bank Ltd. (ASX: NAB) is probably a better idea because the businesses are more tangible. However, I think Class, Pro Medicus and Nanosonics offer the potential for superior long-term returns.

Combining share price growth and dividends is the best way to grow your wealth over time, in my opinion.

Introducing... the brand-new "ultimate income solution" from Motley Fool Australia!

Trying to replace a consistent paycheque once you get to retirement is a scary prospect for millions of Australian investors. Will your savings last long enough?

Will you be able to maintain the lifestyle you've become accustomed to? How do you draw enough income without tapping your portfolio directly?

These are just a few of the thousands of questions that investors like you have. But only one answer is necessary: Motley Fool Australia's brand-new "ultimate income solution" - Motley Fool Everlasting Income.

To see how Everlasting Income could quickly and easily set you up to pay yourself monthly paycheques like $1,667... $2,500... even $3,333... or more - before this first-ever purely income-based service from Motley Fool Australia opens in a matter of days - just click here.

Motley Fool Contributor Owen Raszkiewicz does not have a financial interest in any company mentioned. Owen welcomes and encourages your feedback. You can follow him on Twitter @OwenRask.

The Motley Fool Australia owns shares of Class Limited and Nanosonics Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

HOT OFF THE PRESSES: My #1 Dividend Pick for 2017!

With its shares up 155% in just the last five years, this ‘under the radar’ consumer favourite is both a hot growth stock AND our expert’s #1 dividend pick for 2017. Now we’re pulling back the curtain for you... And all you have to do to discover the name, code and a full analysis is enter your email below!

Simply enter your email now to receive your copy of our brand-new FREE report, “The Motley Fool’s Top Dividend Stock for 2017.”

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.